Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

DAVID A HINCHMAN

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1710914528
CMS profile
122524
Location
BOISE, ID

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$152,409.43

151 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Page 1 of 4; records 1–50 of 151 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

DAVID A HINCHMAN

NPI 1710914528 · CMS profile ID 122524

Allopathic & Osteopathic Physicians / Internal Medicine / Cardiovascular Disease

BOISE, ID

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 4; records 1–50 of 151 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1710914528?year=2025&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
DAVID A HINCHMAN, NPI 1710914528, CMS profile ID 122524. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 4; records 1–50 of 151 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1710914528?year=2025&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). DAVID A HINCHMAN, NPI 1710914528, CMS profile ID 122524. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 4; records 1–50 of 151 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1710914528?year=2025&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
DAVID A HINCHMAN, NPI 1710914528, CMS profile ID 122524, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 4; records 1–50 of 151 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1710914528?year=2025&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

151 matching records · $152,409.43 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 151 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 151.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
BridgeBio Pharma, Inc. $1,710.0012/24/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1250449311 CMS
BridgeBio Pharma, Inc. $48.3012/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250449321 CMS
Alnylam Pharmaceuticals Inc. $2,250.0012/18/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1212772019 CMS
AstraZeneca Pharmaceuticals LP $17.4412/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206562379 CMS
E.R. Squibb & Sons, L.L.C. $23.5912/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184915570 CMS
E.R. Squibb & Sons, L.L.C. $115.8212/08/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1184915564 CMS
E.R. Squibb & Sons, L.L.C. $13.6512/08/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1184915566 CMS
E.R. Squibb & Sons, L.L.C. $57.4512/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184915568 CMS
Boston Scientific Corporation $22.6012/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1181390338 CMS
BridgeBio Pharma, Inc. $1,710.0012/05/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1250449309 CMS
BridgeBio Pharma, Inc. $1,710.0012/05/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1250449315 CMS
BridgeBio Pharma, Inc. $1,710.0011/25/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1250449313 CMS
BridgeBio Pharma, Inc. $47.8911/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250449319 CMS
GENZYME CORPORATION $29.4411/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233308553 CMS
BridgeBio Pharma, Inc. $4,275.0011/13/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1250449307 CMS
E.R. Squibb & Sons, L.L.C. $7,160.0011/13/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1184915556 CMS
Lilly USA, LLC $15.3611/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186625117 CMS
Lilly USA, LLC $1.3511/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186637121 CMS
PFIZER INC. $24.6811/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229520208 CMS
Novartis Pharmaceuticals Corporation $15.4111/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200234363 CMS
BridgeBio Pharma, Inc. $3,847.0011/04/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1250449317 CMS
PFIZER INC. $3,125.0010/29/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1229819520 CMS
AstraZeneca Pharmaceuticals LP $16.2610/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206572812 CMS
AstraZeneca Pharmaceuticals LP $107.8110/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1207108180 CMS
E.R. Squibb & Sons, L.L.C. $134.1810/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184915558 CMS
E.R. Squibb & Sons, L.L.C. $236.8110/23/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1184915560 CMS
E.R. Squibb & Sons, L.L.C. $216.0610/23/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1184915562 CMS
Lilly USA, LLC $1,040.0010/23/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1186568990 CMS
Lilly USA, LLC $785.0010/23/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1186650439 CMS
E.R. Squibb & Sons, L.L.C. $67.6610/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184915516 CMS
E.R. Squibb & Sons, L.L.C. $18.1810/08/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1184915520 CMS
E.R. Squibb & Sons, L.L.C. $76.1110/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184915522 CMS
E.R. Squibb & Sons, L.L.C. $18.9510/08/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1184915532 CMS
Lilly USA, LLC $23.8210/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186637123 CMS
BridgeBio Pharma, Inc. $17,100.0010/07/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1253500085 CMS
Novartis Pharmaceuticals Corporation $18.3210/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200234365 CMS
E.R. Squibb & Sons, L.L.C. $2,685.0010/02/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1184915512 CMS
E.R. Squibb & Sons, L.L.C. $7,697.0010/02/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1184915530 CMS
E.R. Squibb & Sons, L.L.C. $16.4409/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184915538 CMS
AstraZeneca Pharmaceuticals LP $16.2209/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206217486 CMS
Baxter Healthcare $24.6709/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1181547135 CMS
Alnylam Pharmaceuticals Inc. $23.1309/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212771993 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.7809/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223005418 CMS
Boston Scientific Corporation $19.3509/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1181390336 CMS
E.R. Squibb & Sons, L.L.C. $920.3109/12/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1184915514 CMS
E.R. Squibb & Sons, L.L.C. $117.5109/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184915518 CMS
E.R. Squibb & Sons, L.L.C. $743.4609/12/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1184915524 CMS
E.R. Squibb & Sons, L.L.C. $369.0309/12/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1184915526 CMS
E.R. Squibb & Sons, L.L.C. $578.6409/12/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1184915528 CMS
BridgeBio Pharma, Inc. $7,695.0009/09/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1253500083 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $181.14 11
PY2021 $168.75 5
PY2022 $11,464.89 18
PY2023 $71,624.38 127
PY2024 $88,566.54 158
PY2025 $152,409.43 151

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $2,669.33 1
PY2025 Principal investigator $312,600.42 16
PY2024 Recipient $70,959.20 2
PY2024 Principal investigator $52,849.00 4
PY2023 Principal investigator $65,514.00 33
PY2022 Recipient $13,862.00 1
PY2022 Principal investigator $212,977.69 60
PY2021 Principal investigator $197,207.64 41
PY2020 Principal investigator $175,269.34 38
PY2019 Principal investigator $288,116.48 44

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

17 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Cleerly, Inc. $3,069.00 10/08/2025 Non-covered Recipient Entity
CARE Institute- High Desert
TRANSFORM No dispute reported 06/30/2026 1241149060
Principal investigator 1 Cleerly, Inc. $5,549.28 09/22/2025 Non-covered Recipient Entity
CARE Institute- High Desert
TRANSFORM No dispute reported 06/30/2026 1241149026
Principal investigator 1 Cleerly, Inc. $6,116.88 09/05/2025 Non-covered Recipient Entity
CARE Institute- High Desert
TRANSFORM No dispute reported 06/30/2026 1241149045
Principal investigator 1 Eli Lilly and Company $2,645.00 08/26/2025 Non-covered Recipient Entity
CARE INSTITUTE LLC
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFECT OF LEPODISIRAN ON THE REDUCTION OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN ADULTS WITH ELEVATED LIPOPROTEIN(A) WHO HAVE ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE OR ARE AT RISK FOR A FIRST CARDIOVASCULAR EVENT - ACCLAIM-LP(A) No dispute reported 06/30/2026 1187876699
Principal investigator 1 Cleerly, Inc. $2,027.52 08/14/2025 Non-covered Recipient Entity
CARE Institute- High Desert
TRANSFORM No dispute reported 06/30/2026 1241148992
Principal investigator 1 Amgen Inc. $27,453.23 08/01/2025 Non-covered Recipient Entity
CARE INSTITUTE LLC
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Maridebart Cafraglutide on Mortality and Morbidity in Participants Living With Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF) No dispute reported 06/30/2026 1246640061
Principal investigator 1 Cleerly, Inc. $3,058.44 07/08/2025 Non-covered Recipient Entity
CARE Institute- High Desert
TRANSFORM No dispute reported 06/30/2026 1241148954
Principal investigator 1 Cleerly, Inc. $1,013.76 07/08/2025 Non-covered Recipient Entity
CARE Institute- High Desert
TRANSFORM No dispute reported 06/30/2026 1241148980
Principal investigator 1 Amgen Inc. $5,118.98 06/17/2025 Non-covered Recipient Entity
HIGH DESERT HEART AND VASCULAR
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Maridebart Cafraglutide on Mortality and Morbidity in Participants Living With Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF) No dispute reported 06/30/2026 1246642273
Principal investigator 1 Cleerly, Inc. $4,625.28 06/06/2025 Non-covered Recipient Entity
CARE Institute- High Desert
TRANSFORM No dispute reported 06/30/2026 1241148915
Principal investigator 1 AstraZeneca Pharmaceuticals LP $250.00 05/15/2025 Covered Recipient Teaching Hospital
St. Lukes Regional Medical Center
Dapagliflozin in Acute Decompensated Heart Failure No dispute reported 06/30/2026 1185555071
Principal investigator 1 Amgen Inc. $32,131.05 04/23/2025 Covered Recipient Teaching Hospital
St. Lukes Regional Medical Center
A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Olpasiran on Major Cardiovascular Events in Participants With Atherosclerotic Cardiovascular Disease and Elevated Lipoprotein(a) No dispute reported 06/30/2026 1246638210
Principal investigator 1 Cleerly, Inc. $12,408.00 04/23/2025 Non-covered Recipient Entity
CARE Institute- High Desert
TRANSFORM No dispute reported 06/30/2026 1241148884
Principal investigator 1 Cleerly, Inc. $2,680.00 04/23/2025 Non-covered Recipient Entity
CARE Institute- High Desert
TRANSFORM No dispute reported 06/30/2026 1241148888
Recipient Eli Lilly and Company $2,669.33 02/25/2025 Covered Recipient Physician A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFECT OF LEPODISIRAN ON THE REDUCTION OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN ADULTS WITH ELEVATED LIPOPROTEIN(A) WHO HAVE ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE OR ARE AT RISK FOR A FIRST CARDIOVASCULAR EVENT - ACCLAIM-LP(A) No dispute reported 06/30/2026 1187873843
Principal investigator 1 AstraZeneca Pharmaceuticals LP $5,056.00 02/14/2025 Non-covered Recipient Entity
ST LUKES
Dapagliflozin in Acute Decompensated Heart Failure No dispute reported 06/30/2026 1185555067
Principal investigator 1 Eli Lilly and Company $199,398.00 01/07/2025 Non-covered Recipient Entity
CARE INSTITUTE LLC
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFECT OF LEPODISIRAN ON THE REDUCTION OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN ADULTS WITH ELEVATED LIPOPROTEIN(A) WHO HAVE ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE OR ARE AT RISK FOR A FIRST CARDIOVASCULAR EVENT - ACCLAIM-LP(A) No dispute reported 06/30/2026 1187878691